Kura Oncology公司(KURA)在2025年2月26日星期三的盘后交易中股价大涨6.69%,引起市场广泛关注。
公司发布的最新财报数据显示,其第四季度GAAP每股亏损为0.22美元,优于分析师一致预期的0.65美元亏损,超出预期幅度高达66.15%;同时,公司季度销售额达到5388万美元,远高于市场预期的850万美元,增长幅度超过533.92%。
财报数据明显超出市场预期,反映出公司业绩和发展势头良好,投资者对此反应积极,推动了公司股价在盘后市场的大涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.